Citadel Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.8M Buy
812,195
+326,318
+67% +$14M 0.01% 1710
2025
Q4
$21.3M Sell
485,877
-154,404
-24% -$6.39M ﹤0.01% 2272
2025
Q3
$26.4M Buy
640,281
+514,636
+410% +$20.7M ﹤0.01% 1999
2025
Q2
$5.54M Buy
+125,645
New +$5.02M ﹤0.01% 3926
2025
Q1
Sell
-159,663
Closed -$5.69M 14770
2024
Q4
$5.32M Sell
159,663
-359,738
-69% -$11.7M ﹤0.01% 3865
2024
Q3
$13.5M Buy
519,401
+483,147
+1,333% +$12M ﹤0.01% 2505
2024
Q2
$815K Sell
36,254
-143,201
-80% -$3.18M ﹤0.01% 7009
2024
Q1
$4.26M Sell
179,455
-445,193
-71% -$9.9M ﹤0.01% 4194
2023
Q4
$15M Buy
624,648
+438,398
+235% +$9.53M ﹤0.01% 2342
2023
Q3
$4.07M Sell
186,250
-448,773
-71% -$9.39M ﹤0.01% 3985
2023
Q2
$12.1M Sell
635,023
-2,967,064
-82% -$57.2M ﹤0.01% 2422
2023
Q1
$69.9M Buy
3,602,087
+2,468,177
+218% +$43M 0.02% 838
2022
Q4
$18.2M Sell
1,133,910
-401,067
-26% -$6.54M ﹤0.01% 2068
2022
Q3
$24.1M Sell
1,534,977
-137,435
-8% -$2.66M 0.01% 1694
2022
Q2
$34.8M Buy
1,672,412
+1,607,162
+2,463% +$33.1M 0.01% 1329
2022
Q1
$1.48M Sell
65,250
-406,300
-86% -$7.94M ﹤0.01% 6754
2021
Q4
$8.62M Buy
471,550
+51,247
+12% +$981K ﹤0.01% 3321
2021
Q3
$8.88M Sell
420,303
-3,324,550
-89% -$61.7M ﹤0.01% 3270
2021
Q2
$68.2M Buy
3,744,853
+86,813
+2% +$2.02M 0.02% 902
2021
Q1
$82.6M Buy
3,658,040
+3,531,427
+2,789% +$79.8M 0.02% 689
2020
Q4
$2.54M Sell
126,613
-58,977
-32% -$1.23M ﹤0.01% 4859
2020
Q3
$4.54M Buy
+185,590
New +$4.33M ﹤0.01% 3302
2020
Q2
Sell
-2,090,356
Closed -$48.4M 9972
2020
Q1
$36M Buy
2,090,356
+518,402
+33% +$9.48M 0.02% 812
2019
Q4
$27.7M Buy
1,571,954
+375,644
+31% +$6.37M 0.01% 1197
2019
Q3
$21.2M Sell
1,196,310
-163,043
-12% -$3.3M 0.01% 1419
2019
Q2
$29M Buy
1,359,353
+1,027,938
+310% +$21.5M 0.01% 1101
2019
Q1
$7.89M Sell
331,415
-94,780
-22% -$2.16M ﹤0.01% 2363
2018
Q4
$8.38M Sell
426,195
-1,184,929
-74% -$21.1M ﹤0.01% 2118
2018
Q3
$28.5M Sell
1,611,124
-140,063
-8% -$2.73M 0.01% 1117
2018
Q2
$37.7M Buy
1,751,187
+32,368
+2% +$669K 0.02% 862
2018
Q1
$38.1M Buy
1,718,819
+1,002,822
+140% +$27.7M 0.02% 731
2017
Q4
$21.8M Sell
715,997
-153,639
-18% -$4.09M 0.01% 1112
2017
Q3
$21.1M Sell
869,636
-67,773
-7% -$1.8M 0.02% 1035
2017
Q2
$23.1M Sell
937,409
-329,505
-26% -$6.97M 0.02% 910
2017
Q1
$27.5M Sell
1,266,914
-162,084
-11% -$3.3M 0.03% 766
2016
Q4
$21.3M Buy
1,428,998
+438,796
+44% +$6.33M 0.02% 836
2016
Q3
$12.7M Sell
990,202
-1,614,473
-62% -$17.5M 0.01% 1168
2016
Q2
$20.3M Buy
2,604,675
+881,147
+51% +$5.08M 0.02% 775
2016
Q1
$6.89M Sell
1,723,528
-5,374,098
-76% -$22.7M 0.01% 1495
2015
Q4
$40M Buy
+7,097,626
New +$39.7M 0.04% 492
2015
Q3
Sell
-2,448,559
Closed -$13.3M 8967
2015
Q2
$9.21M Buy
2,448,559
+2,196,044
+870% +$7.14M 0.01% 1534
2015
Q1
$649K Buy
252,515
+168,436
+200% +$391K ﹤0.01% 4525
2014
Q4
$121K Buy
84,079
+65,321
+348% +$102K ﹤0.01% 6483
2014
Q3
$29K Sell
18,758
-222,901
-92% -$715K ﹤0.01% 7229
2014
Q2
$820K Sell
241,659
-17,902
-7% -$61.8K ﹤0.01% 3754
2014
Q1
$919K Buy
259,561
+83,367
+47% +$568K ﹤0.01% 3529
2013
Q4
$1.08M Buy
176,194
+88,878
+102% +$490K ﹤0.01% 3150
2013
Q3
$509K Buy
87,316
+86,447
+9,948% +$447K ﹤0.01% 3801
2013
Q2
$4K Buy
+869
New +$4.12K ﹤0.01% 6354

Other funds holding EXEL

Citadel Advisors's EXEL Position: Q1 2026 in Review

Citadel Advisors increased its Exelixis (EXEL) stake by 67% in Q1 2026, buying an estimated $14M and bringing the position to 812,195 shares worth $34.8M. The position accounts for 0.01% of the portfolio, ranked #1710.

Citadel Advisors first reported a position in EXEL in Q2 2013 and has held it in 49 quarters since. The position peaked at $82.6M in Q1 2021. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Citadel Advisors held 812,195 shares of Exelixis worth $34.8M as of Q1 2026.
  • Citadel Advisors bought 326,318 Exelixis shares in Q1 2026, an estimated $14M.
  • Exelixis made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1710 holding.
  • Citadel Advisors first reported a position in Exelixis in Q2 2013 and has held it in 49 quarters since.
  • Citadel Advisors's Exelixis position peaked at $82.6M in Q1 2021.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.